The impact of fetal compromise on outcome at the border of viability
- PMID: 9609558
- DOI: 10.1016/s0002-9378(98)70522-8
The impact of fetal compromise on outcome at the border of viability
Abstract
Objective: Our goal was to evaluate the impact of fetal compromise on the outcome of borderline viable babies.
Study design: All 142 babies born in our hospital from 1990 to 1995 with a gestational age of 23 to 25 weeks were included. Fetal compromise was considered present if one of the following was documented: a major anomaly, congenital sepsis, chronic intrauterine infection, intrauterine drug exposure, congenital anemia, severe growth restriction, fetal acidosis, or cardiorespiratory and neurologic depression in the delivery room.
Results: The 43 babies who had at least one cause of fetal compromise had a lower birth weight (p < 0.001), but there were no other differences in demographics or complications of prematurity. The survival rate was significantly better for babies free of fetal compromise (75% vs 33%, p < 0.001), particularly for babies born at 23 weeks of gestation (75% vs 6%, p < 0.001). For surviving babies free of fetal compromise, the outcome at 23 weeks was comparable to that at 24 to 25 weeks for major causes of long-term neurologic morbidity.
Conclusions: Like advancing gestational age and increasing birth weight, the absence of fetal compromise has a major beneficial impact on the outcome of borderline viable babies that might be important when decisions are made about the appropriate level of support.
Similar articles
-
Comparative outcome of low birth weight babies.Indian Pediatr. 1993 Jan;30(1):15-21. Indian Pediatr. 1993. PMID: 8406701
-
The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.Am J Obstet Gynecol. 2001 Apr;184(5):946-53. doi: 10.1067/mob.2001.111719. Am J Obstet Gynecol. 2001. PMID: 11303203
-
[The fate of very early premature babies. Mortality, morbidity and 2-year follow-up in a population of 96 very early premature babies].Rev Fr Gynecol Obstet. 1992 Nov;87(11):533-9. Rev Fr Gynecol Obstet. 1992. PMID: 1480922 French.
-
Paediatric consequences of fetal growth restriction.Semin Fetal Neonatal Med. 2004 Oct;9(5):411-8. doi: 10.1016/j.siny.2004.03.005. Semin Fetal Neonatal Med. 2004. PMID: 15691777 Review.
-
The small fetus: growth-retarded and preterm.Clin Obstet Gynaecol. 1982 Dec;9(3):517-37. Clin Obstet Gynaecol. 1982. PMID: 6756748 Review.
Cited by
-
Early Onset Intrauterine Growth Restriction-Data from a Tertiary Care Center in a Middle-Income Country.Medicina (Kaunas). 2022 Dec 21;59(1):17. doi: 10.3390/medicina59010017. Medicina (Kaunas). 2022. PMID: 36676641 Free PMC article.
-
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.BMC Pregnancy Childbirth. 2017 Dec 28;17(1):440. doi: 10.1186/s12884-017-1594-z. BMC Pregnancy Childbirth. 2017. PMID: 29282009 Free PMC article. Clinical Trial.
-
STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis.Syst Rev. 2014 Mar 11;3:23. doi: 10.1186/2046-4053-3-23. Syst Rev. 2014. PMID: 24618418 Free PMC article.
-
Increasing illness severity in very low birth weight infants over a 9-year period.BMC Pediatr. 2006 Feb 6;6:2. doi: 10.1186/1471-2431-6-2. BMC Pediatr. 2006. PMID: 16460568 Free PMC article.
-
Prospective study of early and late outcomes of extremely low birthweight in Central Saudi Arabia.BMC Pediatr. 2018 Aug 22;18(1):280. doi: 10.1186/s12887-018-1248-y. BMC Pediatr. 2018. PMID: 30134865 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical